Closing Strong: Apogee Therapeutics Inc (APGE) Ends at 52.79, Down -7.95 from Last Close

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $57.35 in the prior trading day, Apogee Therapeutics Inc (NASDAQ: APGE) closed at $52.79, down -7.95%. In other words, the price has decreased by -$7.95 from its previous closing price. On the day, 0.56 million shares were traded. APGE stock price reached its highest trading level at $58.29 during the session, while it also had its lowest trading level at $51.525.

Ratios:

Our goal is to gain a better understanding of APGE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.39 and its Current Ratio is at 16.39. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on May 10, 2024, initiated with a Buy rating and assigned the stock a target price of $80.

On December 20, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $43.

On August 08, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $40.Wedbush initiated its Outperform rating on August 08, 2023, with a $40 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 06 ’24 when Dambkowski Carl sold 6,665 shares for $59.12 per share. The transaction valued at 394,041 led to the insider holds 267,463 shares of the business.

HENDERSON MICHAEL THOMAS sold 15,000 shares of APGE for $888,320 on Nov 06 ’24. The Chief Executive Officer now owns 1,339,487 shares after completing the transaction at $59.22 per share. On Nov 06 ’24, another insider, HENDERSON MICHAEL THOMAS, who serves as the Officer of the company, bought 15,000 shares for $59.23 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APGE now has a Market Capitalization of 3003904256 and an Enterprise Value of 2863900672.

Stock Price History:

Over the past 52 weeks, APGE has reached a high of $72.29, while it has fallen to a 52-week low of $14.91. The 50-Day Moving Average of the stock is -3.54%, while the 200-Day Moving Average is calculated to be 6.46%.

Shares Statistics:

The stock has traded on average 388.91K shares per day over the past 3-months and 424180 shares per day over the last 10 days, according to various share statistics. A total of 37.17M shares are outstanding, with a floating share count of 36.11M. Insiders hold about 38.26% of the company’s shares, while institutions hold 80.09% stake in the company. Shares short for APGE as of 1728950400 were 6865071 with a Short Ratio of 17.51, compared to 1726185600 on 8185156. Therefore, it implies a Short% of Shares Outstanding of 6865071 and a Short% of Float of 17.849999999999998.

Most Popular